The global Medical Device Contract Manufacturing market size was $73.61 billion in 2023 and is projected to reach $81.19 ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in ...

That said, people with Medicare Part B are typically covered and will not have to pay out of pocket. An insulin pen is a device that contains insulin. Within the pen are vials or cartridges of insulin ...

Around 20 years ago, NovoPen ® became the first commercially available insulin pen device and heralded the introduction of this form of treatment for use in diabetes regimens. These devices ...

The insulin is injected through a needle. Some pens use cartridges inserted into the pen, while others are prefilled and discarded after use. The insulin dose is dialed on the pen, and the insulin is ...